313 related articles for article (PubMed ID: 22459947)
1. BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction.
Shubin NJ; Chung CS; Heffernan DS; Irwin LR; Monaghan SF; Ayala A
J Leukoc Biol; 2012 Sep; 92(3):593-603. PubMed ID: 22459947
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Innate Inflammation Induced by Anti-BTLA Antibody in Dual Insult Model of Hemorrhagic Shock/Sepsis.
Cheng T; Bai J; Chung CS; Chen Y; Biron BM; Ayala A
Shock; 2016 Jan; 45(1):40-9. PubMed ID: 26674453
[TBL] [Abstract][Full Text] [Related]
3. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044
[TBL] [Abstract][Full Text] [Related]
4. B and T lymphocyte attenuator tempers early infection immunity.
Sun Y; Brown NK; Ruddy MJ; Miller ML; Lee Y; Wang Y; Murphy KM; Pfeffer K; Chen L; Kaye J; Fu YX
J Immunol; 2009 Aug; 183(3):1946-51. PubMed ID: 19587015
[TBL] [Abstract][Full Text] [Related]
5. Cutting Edge: the BTLA-HVEM regulatory pathway interferes with protective immunity to intestinal Helminth infection.
Breloer M; Hartmann W; Blankenhaus B; Eschbach ML; Pfeffer K; Jacobs T
J Immunol; 2015 Feb; 194(4):1413-6. PubMed ID: 25595777
[TBL] [Abstract][Full Text] [Related]
6. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM.
Murphy TL; Murphy KM
Annu Rev Immunol; 2010; 28():389-411. PubMed ID: 20307212
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells.
Jones A; Bourque J; Kuehm L; Opejin A; Teague RM; Gross C; Hawiger D
Immunity; 2016 Nov; 45(5):1066-1077. PubMed ID: 27793593
[TBL] [Abstract][Full Text] [Related]
8. T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.
Rodriguez-Barbosa JI; Fernandez-Renedo C; Moral AMB; Bühler L; Del Rio ML
Cell Mol Immunol; 2017 Jun; 14(6):497-510. PubMed ID: 26924526
[TBL] [Abstract][Full Text] [Related]
9. Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors.
Demerlé C; Gorvel L; Mello M; Pastor S; Degos C; Zarubica A; Angelis F; Fiore F; Nunes JA; Malissen B; Greillier L; Guittard G; Luche H; Barlesi F; Olive D
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37230538
[TBL] [Abstract][Full Text] [Related]
10. BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection.
Steinberg MW; Huang Y; Wang-Zhu Y; Ware CF; Cheroutre H; Kronenberg M
PLoS One; 2013; 8(10):e77992. PubMed ID: 24205057
[TBL] [Abstract][Full Text] [Related]
11. High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease.
Aubergeon L; Sawaf M; Felten R; Gottenberg JE; Dumortier H; Monneaux F
Front Immunol; 2021; 12():767099. PubMed ID: 34899718
[TBL] [Abstract][Full Text] [Related]
12. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.
Cheung TC
Recent Pat DNA Gene Seq; 2009; 3(3):177-82. PubMed ID: 19702559
[TBL] [Abstract][Full Text] [Related]
13. Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants.
del Rio ML; Kaye J; Rodriguez-Barbosa JI
Immunobiology; 2010 Jul; 215(7):570-8. PubMed ID: 19837478
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells.
Tao R; Wang L; Murphy KM; Fraser CC; Hancock WW
J Immunol; 2008 May; 180(10):6649-55. PubMed ID: 18453584
[TBL] [Abstract][Full Text] [Related]
15. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.
Cai G; Freeman GJ
Immunol Rev; 2009 May; 229(1):244-58. PubMed ID: 19426226
[TBL] [Abstract][Full Text] [Related]
16. Distinct Changes of BTLA and HVEM Expressions in Circulating CD4
Liu J; Li J; He M; Zhang GL; Zhao Q
J Immunol Res; 2018; 2018():4561571. PubMed ID: 30116751
[TBL] [Abstract][Full Text] [Related]
17. Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway.
Sakoda Y; Park JJ; Zhao Y; Kuramasu A; Geng D; Liu Y; Davila E; Tamada K
Blood; 2011 Feb; 117(8):2506-14. PubMed ID: 21220749
[TBL] [Abstract][Full Text] [Related]
18. B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients.
Shubin NJ; Monaghan SF; Heffernan DS; Chung CS; Ayala A
Crit Care; 2013 Nov; 17(6):R276. PubMed ID: 24289156
[TBL] [Abstract][Full Text] [Related]
19. B and T lymphocyte attenuator regulates the development of antigen-induced experimental conjunctivitis.
Ishida W; Fukuda K; Kajisako M; Sumi T; Matsuda H; Yagita H; Fukushima A
Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):289-95. PubMed ID: 21779950
[TBL] [Abstract][Full Text] [Related]
20. Herpes Virus Entry Mediator (HVEM) Expression Promotes Inflammation/ Organ Injury in Response to Experimental Indirect-Acute Lung Injury.
Cheng T; Bai J; Chung CS; Chen Y; Fallon EA; Ayala A
Shock; 2019 Apr; 51(4):487-494. PubMed ID: 30531604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
